CannPal Animal Therapeutics Limited (“CannPal”) is a pharmaceutical-focused animal health Company researching the benefits of medical cannabis for companion animals. The Company listed on the Australian Stock Exchange (ASX) in 2017, trading under the ASX ticker “CP1”. CannPal was founded to research, develop and commercialise, regulatory approved medicines derived from the medical cannabis plant to provide veterinarians with clinically validated and standardised therapeutics to treat animals in a safe and ethical way.

CannPal has identified a significant opportunity to benefit from the rapidly growing medical cannabis and animal health markets by developing innovative therapeutics using cannabinoids. The Company is working closely with regulatory authorities and veterinary research organisations conducting clinical trials to commercialise therapeutic products that will meet regulatory approval and support the health and well-being of companion animals.

For media inquiries, please email

For general inquiries, please email or contact us.


Geoff StarrNon-Executive Chairman
Layton MillsManaging Director
Max JohnstonNon-Executive Director
Robert CliffordNon-Executive Director
Dr Kate AdamsNon-Executive Director

Company Secretary

Baden Bowen

Corporate Inquiries

Justin Klintberg
Merchant Corporate Advisory

Media enquiries

Julia Maguire
The Capital Network
M: +61 (0)419 815 386

Registered Office

Level 3
45A Bay Street
Double Bay NSW 2028

Telephone: +61 (02) 6108 3622

Share Registry

Computershare Investor Services Pty Limited
Level 11
172 St Georges Terrace
Perth WA 6000

ASX Code



Steinepreis Paganin
Level 4, The Read Buildings
16 Milligan Street
Perth WA 6000


BDO Audit (WA) Pty Ltd
38 Station Street
Subiaco WA 6008

When was the Company founded?

The Company was founded in June 2016.

How can I buy and sell shares?

Cannpal’s shares are traded on the ASX and can be bought or sold through a Licensed Stock Broker. The process of buying or selling shares is explained on the ASX website.

Where can I view the Company prospectus?

You can view the Cannpal prospectus here.

What is the Company's ASX code?

The Company’s ASX code is CP1

Where can I find information about my Shareholdings?

The CannPal share register is managed by Computershare Investor Services Pty Ltd (Computershare). Computershare provides a number of services which can be accessed online. When accessing some information online you may be required to enter your Security Reference Number (SRN) or Holder Identification Number (HIN) as shown on your Issuer Sponsored/CHESS statements and other personal details such as your postcode.

Please contact Computershare if you have any inquiries. It will assist if you can quote your current address together with your Security Reference Number (SRN) or Holder Identification Number (HIN) as shown on your Issuer Sponsored/CHESS statements.

Computershare Investor Services Pty Ltd

: 1300 367 027
International: (+61 3) 9946 4421


Postal address
The Registrar Computershare Investor Services Pty Ltd
GPO Box 2975

Office address
Level 11, 172 St George’s Terrace

Who can I contact about media inquiries?

Media enquiries

Julia Maguire

The Capital Network

M: +61 419 815 386


Is Cannabis legal for animals?

No. In all jurisdictions around the world that we are aware of, Cannabis for animals is illegal, unless it’s being used for medical research purposes and with necessary permits.

How can I treat my animal with medical cannabis?

You should always seek professional advice from a veterinarian when treating animals for any illness. Unfortunately we cannot give you advice, but we are working towards having our products scientifically tested, validated and labelled correctly to inform and allow veterinarians to prescribe medical cannabis medications for animals.

When can I buy your products?

CannPal is working with regulatory authorities to validate the safety and efficacy of medical cannabis for use in companion pets. This is an arduous process and involves robust clinical studies that take time. This process in its entirety can take 3 to 4 years and in some cases more.

However medical cannabis is an evolving industry and while we will continue to complete the required safety and efficacy studies to show our products are safe and efficacious for regulatory authorities to have our medicines approved to be sold by veterinarians, we are following the legislative changes closely should there be an opportunity to enter a legal market earlier than anticipated.

We are also research the benefits of both hemp and CBD derived from hemp, which aren’t bound by the same legislative rules as medical cannabis and we are working on developing a nutraceutical product for market as early as 2018.

Is cannabis dangerous for pets?

Cannabis can be dangerous for animals when taken incorrectly. Dogs have more cannabinoid receptors than humans and can be very sensitive to THC, the psychoactive cannabinoid in cannabis. If you suspect your dog has consumed marijuana without your supervision, take them to the vet immediately. The following signs indicate that your dog may have consumer too much cannabis:

  • Dribbling urine
  • Walking like they’re intoxicated
  • Beginning to fall over while standing still
  • Low heart rate
  • Low blood pressure
  • Wide, dilated pupils
  • Easily startled by sudden sounds

However when consumed in the correct ratios of cannabinoids and dosages, and under medical supervision, cannabis is a wonderful medicine for a range of ailments and we’re working to be able to provide pet owners with safe, standardised and dosage controlled medicines using cannabis.

Where can I view the Company's corporate governance plan?

You can view all the Company’s policies and the corporate governance plan here